GLP-1 RA users were then categorized into 4 study groups at the yearly level based on whether they had a diagnosis code for diabetes or obesity/overweight within 365 days (1 year) of the index date: (1) members who had an International Statistical Classification of Diseases, Tenth Revision diagnosis code for diabetes (E10x, E11x, and E13x) in at least 1 inpatient or outpatient claim and no obesity/overweight diagnosis code (Z682x, Z683x, Z684x, E660x, E663, E669)
Tirzepatide is administered as a once-weekly subcutaneous injection, with dosing typically initiated at 2.5 mg and gradually titrated upward based on therapeutic response and tolerability
Retrieved on August 02, 2026 from MLA Bose, Priyom
WeightSnap Every tracker on this page charts your weight and logs your doses
It usually takes four to six months until you begin to find any results, but you should observe a change almost instantly